Leaflet LEVOMEPROMAZIN TERAPIA 25mg tablets
Indicated for: schizophrenia; bipolar disorder
Route of administration: oral
Substance: levomepromazine (antipsychotic)
ATC: N05AA02 (Nervous system | Antipsychotics | Phenothiazines with aliphatic side-chain)
This medicine may affect your ability to drive or use machines.
This medicine may cause dizziness or vertigo.
This medicine may increase blood sugar.
This medicine may increase the risk of heart rhythm disturbances.
This medicine may increase the risk of seizures.
This medicine may cause drowsiness or reduced alertness.
Levomepromazine is an antipsychotic medication used to treat schizophrenia and other psychotic disorders. It is also used to alleviate symptoms of severe agitation, anxiety, or insomnia.
This medication belongs to the class of typical antipsychotics and works by blocking dopamine receptors in the brain, which helps reduce psychotic symptoms such as hallucinations and delusions.
Levomepromazine is administered orally or by injection, and the dosage is adjusted based on the severity of symptoms and the patient's response. Side effects may include drowsiness, dizziness, dry mouth, weight gain, or low blood pressure.
Patients should be regularly monitored by their doctor, especially if they have other medical conditions or are taking other medications. Pregnant or breastfeeding women should consult a specialist before using this medication.
General data about LEVOMEPROMAZIN TERAPIA 25mg
- Substance: levomepromazine
- Date of latest medicines list: 01-06-2026
- Product code: W03959001
- Concentration: 25mg
- Pharmaceutical form: tablets
- Quantity: 20
- Product type: Generic medicine
- Price: 41.52 RON
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for levomepromazine
- 100mg
- 25mg